INTERNATIONAL PATENT: MEDIMMUNE LLC FILES APPLICATION FOR "CD22 ANTIBODY AND DRUG CONJUGATES AND USES THEREOF"

GENEVA, April 18 -- MEDIMMUNE LLC (One MedImmune WayGaithersburg, Maryland 20878) filed a patent application (PCT/IB2025/060233) for "CD22 ANTIBODY AND DRUG CONJUGATES AND USES THEREOF" on Oct 09, 2025. With publication no. WO/2026/078620, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MARELLI, Marcello (c/o AstraZeneca Pharmaceuticals LP1800 Concord Pike, P.O. Box 15437Wilmington, Delaware 19850-5437), HAN, Huiying (c/o AstraZeneca Pharmaceuticals LP1800 Concord Pike, P.O. Box 15437Wilmington, Delaware 19850-5437), DU, ...